218
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Formulation, characterisation and in vivo evaluation of lipid-based nanocarrier for topical delivery of diflunisal

, &
Pages 475-486 | Received 28 Mar 2016, Accepted 19 Jul 2016, Published online: 08 Aug 2016
 

Abstract

Diflunisal (DIF) is non-steroidal anti-inflammatory drug used in the treatment of rheumatoid arthritis, osteoarthritis. The current engrossment was aimed at formulation and assessment of DIF-loaded solid lipid nanoparticles (SLNs) for topical/dermal application. SLNs formulated by hot homogenisation method based on microemulsification technique were spherical with a mean size of 124.0 ± 2.07 nm; PDI 0.294 ± 0.15. The cumulative amount permeated/area was 109.99 ± 0.008 μg/cm2, along with permeation flux (6.30 ± 0.09 μg/cm2/h) and skin retention (11.74 ± 0.155 μg/cm2) across mice skin. The SLNs of DIF showed significant decrease in fluid volume, granuloma tissue weight, leukocyte count/mm3 after application of SLN formulation in mice air pouch model. Similarly, in mice ear oedema and rat paw oedema model, there was 2.30 and 1.29 time increase in percentage inhibition of oedema after SLN formulation application, respectively, as compared with conventional cream. Hence, the SLNs of DIF may prove to be a potential nanocarrier to effectively treat the local inflammatory conditions associated with arthritis.

Acknowledgements

The authors are thankful to Dr Indu Pal Kaur, Professor of Pharmaceutics, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, and her research group for carrying out the dynamic light scattering studies.

Disclosure statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.